Compare NOG & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NOG | AORT |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.5B | 2.1B |
| IPO Year | 2000 | 1996 |
| Metric | NOG | AORT |
|---|---|---|
| Price | $27.53 | $38.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $29.14 | ★ $48.76 |
| AVG Volume (30 Days) | ★ 1.7M | 461.3K |
| Earning Date | 05-26-2026 | 05-15-2026 |
| Dividend Yield | ★ 6.86% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | ★ 0.39 | 0.21 |
| Revenue | ★ $2,475,723,000.00 | $298,836,000.00 |
| Revenue This Year | $18.95 | $13.95 |
| Revenue Next Year | N/A | $11.16 |
| P/E Ratio | ★ $23.85 | $181.05 |
| Revenue Growth | 11.23 | ★ 18.01 |
| 52 Week Low | $19.88 | $21.97 |
| 52 Week High | $32.62 | $48.25 |
| Indicator | NOG | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 60.94 | 43.81 |
| Support Level | $26.50 | $30.24 |
| Resistance Level | $28.24 | $44.29 |
| Average True Range (ATR) | 1.15 | 1.69 |
| MACD | -0.03 | 0.07 |
| Stochastic Oscillator | 78.41 | 59.44 |
Northern Oil & Gas Inc is an independent energy company engaged in the acquisition, exploration, development, and production of crude oil and natural gas properties. Its principal business is crude oil and natural gas exploration, development, and production. The company's oil and natural gas sales come from three geographic areas in the United States: the Williston Basin (North Dakota and Montana), the Permian Basin (New Mexico and Texas), the Uinta Basin, and the Appalachian Basin (Pennsylvania and Ohio).
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.